A product liability lawsuit has been filed in Philadelphia Court of Common Pleas in June this year. It has been filed by Steven Shemelia. He has accused that his wife Patricia Shemelia died due to side effects of Fentanyl use.

Fentanyl is a narcotic drug used as a painkiller. It is an opioid pain killer drug. It is used for treatment of pain due to breakthrough of cancer, when other medications fail to control it. It is meant for only cancer related pain and is not for normal pain. Doctors prescribe it for other purposes based on their clinical judgment.

Use of Fentanyl could lead to many severe side effects. It could lead to breathing problems, fainting, light-headedness, easy bruising or bleeding, low blood pressure, increased intracranial pressure, respiratory depression, seizure, allergic reactions such as rash, itching or swelling of the face, tongue and throat, hives, difficulty breathing, urination problems, mood changes or hallucinations. It could also lead to abdominal problems.

The above said lawsuit has been filed by the attorney Rosemary Pinto, of the Philadelphia firm Feldman & Pinto on behalf of the plaintiff Steven Shemelia. The case has been filed at the Philadelphia Court of Common Pleas on June 6th. The case is blaming manufacturers of Fentanyl for death of Patricia Shemelia, wife of the plaintiff. The plaintiff hails from New York.

Defendants in the case are Mylan, Inc., Mylan Pharmaceuticals, Inc., and Mylan Technologies, Inc. Mylan, Inc., Mylan Pharmaceuticals, Inc are based in Harrisburg and the Mylan Technologies is based in Vermont. The lawsuit is waiting to be granted a mass tort status.

The lawsuit states that the deceased woman Patricia Shemelia was prescribed with Fentanyl patch in September 2009. She died due to overdose of Fentanyl the very next month. It states that it is far more powerful around 80 times than Morphine. The Fentanyl is only available on prescription as approved by FDA. It is used to treat persistent pain. The patch used by her supplied an overdose of the drug in her blood, which resulted into her death.

The lawsuit blames the manufacturers to be negligent about the amount of drug being delivered into blood stream of patients through these patches. These doses of drug through patches have proved fatal for many patients. There have been many lawsuits filed against Mylan related to overdose of Fentanyl, even then the manufacturer and distributors neglected this fact and marketed the same product containing lethal doses of Fentanyl.

They also neglected adverse event reporting from FDA and similar information from the World Health Organization. It played with life of many patients by ignoring this fact and marketing the patches with overdose of Fentanyl. Patricia Shemelia was one of such patient who died due to overdose of Fentanyl in these patches.

The lawsuit states that the concentration of Fentanyl in Patricia Shemelia’s blood was 17 times higher than the mean maximal fentanyl concentration allowed for a Fentanyl patch, at the time of her death. It imposes charges of strict products liability, breach of implied warranties, breach of express warranties and wrongful death on the makers of Fentanyl patch, Mylan, Inc, Mylan pharmaceuticals and Mylan technologies Inc.

The lawsuit demands for a judgment against all the defendants and severally in an amount in excess of $50,000 for compensation and punitive damages. It also demands for related costs in addition to the compensation and punitive damages.